Concepedia

Aki Kato

AK

2

Publications

56

Citations

2

H-Index

2004

Active since

Affiliations

Pfizer (Japan)(Current)

Aki Kato is an author at Pfizer (Japan) specializing in pain research, health sciences, and medicine.

Top concepts

HealthMedicinePharmacologyPain ResearchNeuropathic PainNeurologyAnalgesicsAnesthesiaBiochemistryBrain Injury

Publications per year

2004–2010

2

Publications

2

Brain but Not Spinal NR2B Receptor Is Responsible for the Anti-Allodynic Effect of an NR2B Subunit-Selective Antagonist CP-101,606 in a Rat Chronic Constriction Injury Model

Etsuko Nakazato, Aki Kato, Shuzo Watanabe · Pharmacology · 2004 · 34 citations

Neuropathic Pain, Molecular Pain, Peripheral Nervous System +24

Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: Design, synthesis, and structure–activity relationships

Shigeo Hayashi, Eriko Nakata, Asato Morita et al. · Bioorganic & Medicinal Chemistry · 2010 · 22 citations · Full text

Pain Disorders, Pain Medicine, Neuropathic Pain +17

Rows per page

1–2 of 2